G. Saydam Et Al. , "Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia," vol.122, 0
Saydam, G. Et Al. Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia. .
Saydam, G., Haznedaroglu, I. C., Kaynar, L., Yavuz, A. S., Ali, R., Guvenc, B., ... Akay, O. M. Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia .
Saydam, Guray Et Al. "Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia,"
Saydam, Guray Et Al. "Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia."
Saydam, G. Et Al. . "Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia." .
@conferencepaper{conferencepaper, author={Guray Saydam Et Al. }, title={Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia}, congress name={}, city={}, country={}, year={0}}